Search results
Promising trial data for Moderna's skin cancer vaccine sends stock rising
Quartz· 20 hours agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 1 day agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 24 hours agoThe vaccine, a critical component of Moderna’s pipeline, has bolstered investor confidence following...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 1 day agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 1 day agoIn the study, Moderna and Merck combined their cancer treatments—Moderna’s experimental cancer vaccine and Merck’s approved checkpoint ...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 4 days agoAs concerns grow about the H5 bird flu, Moderna and fellow Covid jab maker Pfizer say they're ready...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 4 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Reuters via Yahoo News· 5 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 1 day ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...